Jennifer L. Taubert, EVP of Worldwide Commercial for Innovative Medicine at Johnson & Johnson ($JNJ), sold shares on the open market once in the last year, totaling about $10 million. Her most recent sale occurred on September 4, 2025. This places her sales volume 1,118th among nearly 12,000 individual insiders, above the average of $8.6 million per seller and 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 13547 | $244.55 | 192,771.0010 | 2,429,400,000 | 6.57% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 27412 | $0.00 | 206,318.0010 | 2,429,400,000 | 15.32% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 409 | $244.55 | 178,906.0010 | 2,429,400,000 | 0.23% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1302 | $0.00 | 179,315.0010 | 2,429,400,000 | 0.73% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Restricted Share Units | 3940 | $0.00 | 3,940.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Employee Stock Options (Right to Buy) | 54869 | $0.00 | 54,869.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1847 | $0.00 | 3,692.0000 | 2,429,400,000 | 33.35% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1594 | $0.00 | 1,594.0000 | 2,429,400,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Performance Share Units | 27412 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1302 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 945 | $243.45 | 194,451.0010 | 2,429,400,000 | 0.48% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1847 | $0.00 | 195,396.0010 | 2,429,400,000 | 0.95% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 816 | $243.45 | 193,549.0010 | 2,429,400,000 | 0.42% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1594 | $0.00 | 194,365.0010 | 2,429,400,000 | 0.83% | 0.00% |
| Feb. 9, 2026 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Performance Share Units | 27412 | $0.00 | 27,412.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Dec. 31, 2025 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 769 | $305.63 | 3,696.0300 | 712,154,350 | 26.27% | 0.00% |
| Sept. 30, 2025 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 99 | $303.89 | 2,910.1500 | 714,461,139 | 3.51% | 0.00% |
| Sept. 4, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 56471 | $101.87 | 234,484.0010 | 2,429,400,000 | 31.72% | 0.00% |
| Sept. 4, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Employee Stock Options (Right to Buy) | 56471 | $101.87 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Sept. 4, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S | Common Stock | 56471 | $177.81 | 178,013.0010 | 2,429,400,000 | 24.08% | 0.00% |
| June 30, 2025 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 103 | $292.17 | 2,692.4300 | 714,461,139 | 3.96% | 0.00% |
| March 31, 2025 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 96 | $312.37 | 2,676.4400 | 714,461,139 | 3.72% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Employee Stock Options (Right to Buy) | 89781 | $0.00 | 89,781.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Restricted Share Units | 5539 | $0.00 | 5,539.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 15465 | $0.00 | 185,924.0010 | 2,429,400,000 | 9.07% | 0.00% |
| Feb. 13, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1302 | $0.00 | 167,221.0010 | 2,429,400,000 | 0.78% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 410 | $155.26 | 166,811.0010 | 2,429,400,000 | 0.25% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 4053 | $0.00 | 170,864.0010 | 2,429,400,000 | 2.43% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 1348 | $156.71 | 169,516.0010 | 2,429,400,000 | 0.79% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1594 | $0.00 | 171,110.0010 | 2,429,400,000 | 0.94% | 0.00% |
| Feb. 18, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 651 | $156.15 | 170,459.0010 | 2,429,400,000 | 0.38% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 7911 | $156.71 | 178,013.0010 | 2,429,400,000 | 4.25% | 0.00% |
| Feb. 13, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1302 | $0.00 | 1,302.0000 | 2,429,400,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 4053 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1594 | $0.00 | 3,188.0000 | 2,429,400,000 | 33.33% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Performance Share Units | 15465 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Performance Share Units | 15465 | $0.00 | 15,465.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Employee Stock Options (Right to Buy) | 58504 | $100.06 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 58504 | $100.06 | 213,355.0010 | 2,429,400,000 | 37.78% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 47436 | $153.12 | 165,919.0010 | 2,429,400,000 | 22.23% | 0.00% |
| Dec. 31, 2024 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 700 | $289.89 | 2,565.6500 | 0 | 37.56% | 0.00% |
| Sept. 30, 2024 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 99 | $304.51 | 1,751.1000 | 0 | 5.96% | 0.00% |
| June 28, 2024 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 118 | $254.84 | 1,643.2300 | 0 | 7.72% | 0.00% |
| March 29, 2024 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 106 | $281.95 | 1,515.5300 | 0 | 7.55% | 0.00% |
| Feb. 15, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Employee Stock Options (Right to Buy) | 76981 | $0.00 | 76,981.0000 | 2,560,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | A | Restricted Share Units | 4782 | $0.00 | 4,782.0000 | 2,560,400,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Restricted Share Units | 1302 | $0.00 | 2,604.0000 | 2,560,400,000 | 33.33% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 666 | $157.85 | 154,851.0010 | 2,560,400,000 | 0.43% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 1302 | $0.00 | 155,517.0010 | 2,560,400,000 | 0.84% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 3769 | $0.00 | 167,618.0010 | 2,560,400,000 | 2.30% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Performance Share Units | 22433 | $0.00 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M | Common Stock | 22433 | $0.00 | 163,849.0010 | 2,560,400,000 | 15.86% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F | Common Stock | 13403 | $157.40 | 154,215.0010 | 2,560,400,000 | 8.00% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | F | Common Stock | 1913 | $156.33 | 141,416.0010 | 2,560,400,000 | 1.33% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | S | Common Stock | 59397 | $156.27 | 141,416.0010 | 2,560,400,000 | 29.58% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Common Stock | 59397 | $90.44 | 200,813.0010 | 2,560,400,000 | 42.00% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Restricted Share Units | 3739 | $0.00 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Common Stock | 3739 | $0.00 | 143,329.0010 | 2,560,400,000 | 2.68% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Employee Stock Options (Right to Buy) | 59397 | $0.00 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Dec. 31, 2023 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 776 | $296.51 | 1,400.7500 | 0 | 124.10% | 0.00% |
| Sept. 29, 2023 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 109 | $263.44 | 615.2600 | 0 | 21.56% | 0.00% |
| June 30, 2023 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 96 | $298.41 | 503.3700 | 0 | 23.67% | 0.00% |
| March 31, 2023 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Not found | A | Phantom Stock | 103 | $279.61 | 404.9200 | 0 | 34.04% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | A | Restricted Share Units | 3906 | $0.00 | 3,906.0000 | 2,663,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | A | Employee Stock Options (Right to Buy) | 64634 | $0.00 | 64,634.0000 | 2,663,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | A | Common Stock | 21422 | $0.00 | 150,159.0010 | 2,663,900,000 | 16.64% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | F | Common Stock | 10569 | $162.01 | 139,590.0010 | 2,663,900,000 | 7.04% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Common Stock | 3570 | $0.00 | 130,026.0010 | 2,663,900,000 | 2.82% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | F | Common Stock | 1289 | $162.08 | 128,737.0010 | 2,663,900,000 | 0.99% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | M | Restricted Share Units | 3570 | $0.00 | 0.0000 | 2,663,900,000 | 100.00% | 0.00% |
| Dec. 31, 2022 | MCDONALDS CORP | $MCD | Taubert Jennifer L | Director | A | Phantom Stock | 300 | $263.53 | 300.3900 | 0 | 9999.99% | 0.00% |